(Rac) -Eflucimibe

• Description:

  (Rac) -Eflucimibe ((Rac) -F 12511) is an ACAT inhibitor with endogenous hypercholesterolemia modulating activity. (Rac) -Eflucimibe has shown high potency and efficacy as an anti-hypercholesterol compound in different hypercholesterolemia animal models[1].

• Product Name Alternative:

  (Rac) -F 12511

• UNSPSC:

  12352005

• Target:

  Endogenous Metabolite

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/rac-eflucimibe.html

• Smiles:

  O=C(C(C1=CC=CC=C1)SCCCCCCCCCCCC)NC2=C(C)C(C)=C(O)C(C)=C2

• Molecular Formula:

  C29H43NO2S

• Molecular Weight:

  469.72

• References & Citations:

  [1]Time-dependent evaluation of mechanical properties and in vitro cytocompatibility of experimental composite-based nerve guidance conduits

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [191791-65-8]